Evaluation of Primary Failure of New Measles Vaccine and Secondary Failure of Previous Measles Vaccine After Mass Vaccination in Military Cadets in Iran

Authors

Gholamali Ghorbani1,*, Kazem Ahmadi2, Hamidreza Ghadimi3
1Department of Infectious Diseases and Tropical Medicine, Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2Immunology Research Center, Baqyiatallah University of Medical Sciences , Tehran, IR Iran
3Medical researcher, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
*Corresponding Author: Department of Infectious Diseases and Tropical Medicine, Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Email:, [email protected]. Email: [email protected]

Archives of Clinical Infectious Diseases:Vol. 2, issue 3; 129-132
Published online:Jul 31, 2007
Article type:Research Article
How to Cite:Ghorbani G, Ahmadi K, Ghadimi H. Evaluation of Primary Failure of New Measles Vaccine and Secondary Failure of Previous Measles Vaccine After Mass Vaccination in Military Cadets in Iran. Arch Clin Infect Dis. 2007;2(3):. doi:

Abstract

Background:

Measles is an acute highly infectious respiratory viral disease. It remains a leading cause of death among young children especially in developing country. Measles outbreaks occurred in Iran in recent years and soldiers and cadets have been vaccinated against it. This study was designed to evaluate primary and secondary failure of measles

vaccine in cadets after mass measles vaccination.

Materials and Methods:

For this cross-sectional study, one month after mass vaccination in 2003, all vaccinated cadets were recruited. Eight hundred and sixty five cadets were evaluated in a simple random fashion. From each individual 5ml blood sample was obtained and checked in immunology laboratory of Baqiyatallah hospital. Antibody was checked by enzyme-linked immunosorbent assay (ELISA) for qualitative and quantitative measurement of IgG and IgM in accordance with Behring ELISA kit (Germany) instructions. Cut-off OD upper than 0.2 was considered positive andm quantitative titer upper than 345 mIU/ml was considered protective.

Results:

All cadets were men with a mean age of 19.01.1 years. IgM anti-measles antibody was positive in 0.7%. Primary failure was positive in 1.8% of individuals. Anti measles IgG antibody was positive in 97.8% of cadets. History of childhood vaccination for measles was positive in 67.7% and past history of measles was positive in 23 cases (2.6%).

Conclusion:

Our results showed that secondary failure is more than 97%. Therefore, periodic studies should be performed to assess secondary failure rate in order to take preventive measures in time, of course, if its outbreaks are probable to happen.

Full Text

Full text is available in PDF

Copyright

© 2007, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Dec
2013

Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran

Abdolhussein Shakurnia,
Seyed Mohammad Alavi,
Reza Norouzirad,
Amir Arsalan Sarajian,
Ghodratollah Shakerinejad

Shakurnia A, Alavi SM, Norouzirad R, Sarajian AA, Shakerinejad G. Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran. Jundishapur J Microbiol. 2013;6(10):e7707. doi: https://doi.org/10.5812/jjm.7707

8
Sep
2012

Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination

Ahmad Shamsizadeh,
Roya Nikfar,
Manoochehr Makvandi,
Makvandi Hakimzadeh,
Mohsen Alisamir,
Tahereh Ziaei

Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, et al. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol. 2012;5(4):578-581. doi: https://doi.org/10.5812/jjm.4563

14
Aug
2012

Serological Response to Measles Revaccination in a Small Population After a Mass Measles Revaccination Program

Fariba Shirvani,
Parviz Tabatabaee,
Reza Shiari,
Farideh Shiwa,
Mohamad Soltanzadeh

Shirvani F, Tabatabaee P, Shiari R, Shiwa F, Soltanzadeh M. Serological Response to Measles Revaccination in a Small Population After a Mass Measles Revaccination Program. J Compr Ped. 2012;3(1):7-11. doi: https://doi.org/10.17795/compreped-7144

15
Jun
2004

Epidemiologic survey of documented measles outbreak in Tehran

1 Mokhtari,
M Alavi Moghaddam,
D Yadegari,
Masoud Salehi,
F Shahim,
Iraj Zareban

Mokhtari 1, Alavi Moghaddam M, Yadegari D, Salehi M, Shahim F, et al. Epidemiologic survey of documented measles outbreak in Tehran. Zahedan J Res Med Sci. 2004;6(2):e95020. doi:

11
May
2013

Measles Epidemiology in Sistan and Baluchistan Province During April 2006-March 2011

Jalil Nejati,
Narjes Sargolzaie,
Malek Kiani,
Monireh Mahjoob,
Abdorahim Hashemi

Nejati J, Sargolzaie N, Kiani M, Mahjoob M, Hashemi A. Measles Epidemiology in Sistan and Baluchistan Province During April 2006-March 2011. Health Scope. 2013;2(1):58-62. doi: https://doi.org/10.17795/jhealthscope-10353

More by these authors

Gholamali GhorbaniPubMedScholar
Kazem AhmadiPubMedScholar
Hamidreza GhadimiPubMedScholar
Share
Cited by
Metrics